Biopharmaceutical company Amgen (NASDAQ:AMGN) on Tuesday announced a dividend of USD2.52 per share for the first quarter of 2026.
This is an increase from the USD2.38 per share paid in each quarter of the prior year.
Shareholders of record at 13 February 2026 will receive the dividend on 6 March 2026.
Sanofi receives FDA complete response letter for tolebrutinib in progressive MS
Abbott announces quarterly common dividend increase
Amgen announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client